VitriVax, Inc.
About VitriVax, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series B T: - FT: Series B |
A: 17250000 MR: - FA: $17.25 million FAN: 17250000 |
D: 2025-10-22 FD: 2025-10-22 |
2 investors |
| 2 |
RT: Grant T: - FT: Grant |
A: 9900000 MR: - FA: $9.9M FAN: 9900000 |
D: 2025-10-14 FD: 2025-10-14 |
1 investors |
| 3 |
RT: Grant T: - FT: Grant |
A: 3600000 MR: - FA: $3.6 million FAN: 3600000 |
D: 2024-12-04 FD: 2024-12-04 |
1 investors |
| 4 |
RT: Grant T: - FT: Grant |
A: 5000000 MR: - FA: $5M FAN: 5000000 |
D: 2023-12-06 FD: 2023-12-06 |
1 investors |
Growth Metrics
Team & Leadership
Louise Brady
Board Member, Piedmont Capital Partners
Romulo Colindres
Chief Executive Officer
René Lorenz
Investor
Theodore Randolph
Co-Founder
Glenn Rockman
Board Member, Adjuvant Capital
Maria Elena Botazzi
Scientific Advisory Board Member
Recent News
VitriVax, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- vitrivaxbio.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~380 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro